Retatrutide Meta-30 Pen

PEPTIVA RETATRUTIDE META-30 PEN contains Retatrutide, a synthetic single-molecule peptide that acts on three receptors — GIP, GLP-1 and glucagon — supplied as a 30mg/3ml pre-filled research pen.

What it is. Retatrutide is an investigational triple-receptor agonist developed in the incretin field. It is in late-stage clinical trials run by its originator; published Phase 2 data describe body-weight and metabolic endpoints in trial participants. It is not an approved medicine anywhere, and this research material is not a clinical product.

Evidence status. Human data come from sponsor-run trials of the pharmaceutical compound under medical supervision and do not transfer to this material. Research use only — not for human or animal use.

• Triple GIP / GLP-1 / glucagon receptor agonist peptide
• Investigational compound in sponsor-run Phase 3 trials; published Phase 2 data on metabolic endpoints
• Not an approved medicine; trial results do not apply to this research material
• Research use only — not for human or animal use

Store refrigerated at 2°C–8°C. Do not freeze. Protect from light. (As printed on the carton.)

• 1 x Pre-Filled Pen (30mg/3ml)
• 20 x 31G 5mm Needles
• 1 x Instruction Leaflet
• Verification Code Inside

Batch RET2607A01 · Expiry 05/2029. Scan the QR on the back of the carton or verify online. Certificates of Analysis available on request by email.

Supplied strictly as a research material for laboratory and in-vitro use only. Not for human or animal use. Not a medicine, supplement or cosmetic. No information on this page constitutes dosing, administration or therapeutic guidance.